Vascular Lesions Fezal Özdemir V.5

Total Page:16

File Type:pdf, Size:1020Kb

Vascular Lesions Fezal Özdemir V.5 Chapter V.5 Vascular Lesions Fezal Özdemir V.5 Contents V.5.1 Introduction. 303 V.5.5.2 Subcorneal Hematoma. 310 V.5.2 Hemangiomas. 303 V.5.5.2.1 Definition. 310 V.5.2.1 Cherry Hemangioma. 304 V.5.5.2.2 Clinical Features. 310 V.5.2.1.1 Definition. 304 V.5.5.2.3 Dermoscopic Criteria. 310 V.5.2.1.2 Clinical Features. 304 V.5.5.2.4 Relevant Clinical Differential V.5.2.1.3 Dermoscopic Criteria. 304 Diagnoses. 310 V.5.2.1.4 Relevant Clinical Differential V.5.5.2.5 Histopathology. 310 Diagnoses. 304 V.5.5.2.6 Management . 310 V.5.2.1.5 Histopathology. .304 V.5.6 Case Study . 310 V.5.2.1.6 Management . .305 References. 312 V.5.3 Pyogenic Granuloma. 305 V.5.3.1 Definition. 305 V.5.3.2 Clinical Features. 305 V.5.3.3 Dermoscopic Criteria. 305 V.5.1 Introduction V.5.3.4 Relevant Clinical Differential Diagnosis. 306 V.5.3.5 Histopathology. .306 The biological classification of vascular lesions V.5.3.6 Management . .307 into two major categories as tumors and malfor- mations [19] forms a framework for conceiving V.5.4 Angiokeratomas . 307 them in a coherent manner, although evidence V.5.4.1 Solitary Angiokeratoma. 307 for their association has been reported in a small V.5.4.1.1 Definition. 307 minority [9]. Among them, the lesions that V.5.4.1.2 Clinical Features. 307 simulate pigmented skin tumors, especially the V.5.4.1.3 Dermoscopic Criteria. 307 melanoma, are discussed in this chapter. Some V.5.4.1.4 Relevant Clinical Differential of these fall into the category of tumors (hem- Diagnoses. 307 angioma, pyogenic granuloma) and some into V.5.4.1.5 Histopathology. .307 malformations (angiokeratoma). In addition, V.5.4.1.6 Management . .308 subcorneal and subungual hemorrhage is in- V.5.5 Hemorrhages. .308 cluded here for diagnostic purposes. V.5.5.1 Subungual Hematoma. 308 V.5.5.1.1 Definition. 308 V.5.5.1.2 Clinical Features. 308 V.5.2 Hemangiomas V.5.5.1.3 Dermoscopic Criteria. 308 V.5.5.1.4 Histopathology. .308 Hemangiomas are benign vascular tumors V.5.5.1.5 Relevant Clinical Differential due to the proliferation of blood vessels. The Diagnoses. 308 term includes many entities, namely, infantile V.5.5.1.6 Management . .308 hemangiomas (localized, segmental, multifocal, 304 F. Özdemir ­undetermined), congenital hemangiomas (non- involuting, rapidly involuting) [20], cherry hem- angioma, tufted angioma, verrucous hemangio- ma, arteriovenous hemangioma, thrombosed capillary aneurysm, and lobular capillary hem- angioma (pyogenic granuloma). Some of these entities are beyond the scope of this chapter, and some are misnomers, but some will be consid- ered for their unique dermoscopic criteria and resemblance to melanoma. V.5.2.1 Cherry Hemangioma V.5.2.1.1 Definition Cherry hemangiomas (senile angioma, ruby spot, Campbell de Morgan spot) are the most com- mon vascular lesions that appear as small, bright- red papules in adulthood, usually on the trunk. V.5.2.1.2 Clinical Features Cherry hemangiomas vary in size from hardly visible, pinpoint lesions to soft, raised, dome- shaped, bright-red papules with a smooth sur- Fig. V.5.1. a Cherry hemangioma, clinical view. A soft, face measuring several millimeters in diameter polypoid, red-colored papule with a diameter of 4×6 mm (Fig. V.5.1a). The incidence rises sharply in the is shown. b Cherry hemangioma, dermoscopy view. A fourth decade, being almost universal in old typical lacunar pattern with circumscript, round-to-oval red structures, namely, lacunas, is shown age. They develop alone or in groups, several to hundreds in number occurring anywhere on the skin but most commonly on the trunk and proximal extremities [25]. V.5.2.1.4 Relevant Clinical Differential Diagnoses V.5.2.1.3 Dermoscopic Criteria Thrombosed lesions may resemble angiokera- toma or melanoma, which can be differentiated Cherry hemangiomas reveal a typical lacunar by dermoscopy. Pyogenic granuloma differs pattern with red-blue lacunas (or lagoons) [29, with its sudden unset. 34] which are characterized by circumscribed, round-to-oval structures with a color varying from red, red-blue, dark-red to black (Fig. V.5.1b) V.5.2.1.5 Histopathology [2, 16]. Criteria for melanocytic lesions should be absent, which is valid for all vascular lesions Cherry hemangiomas are composed of dilated [3, 30, 34]. Histopathologically, red lacunas rep- capillaries and scant intervening stroma with a V.5 resent dilated blood vessels in the upper dermis, thin epidermal collarette at the periphery. In the and if they are dark-red or black in color, this early stage of development numerous, newly means that they are partially or completely formed capillaries with narrow lumina and thrombosed [16, 29, 33, 34]. prominent endothelial cells, localized in the up- Vascular Lesions Chapter V.5 305 per dermis, become dilated as the lesion ages; face, lips, and oral mucosa, are the sites of predi- thus, in a fully mature lesion, there are numer- lection [7, 22]. Rare multiple lesions may be ous dilated capillaries lined by flattened endo- grouped or eruptive and disseminated in na- thelial cells [4]. These endothelial cells have ture. been shown to have non-replicating nature [31], indicating that cherry hemangioma may not be a true neoplasm. V.5.3.3 Dermoscopic Criteria Pyogenic granuloma has been reported that V.5.2.1.6 Management pyogenic granulomas cannot be diagnosed with more accuracy by dermoscopy than with naked Cherry hemangiomas are usually left alone un- eye [34]. Specific dermoscopic criteria of it have less cosmetically displeasing or prone to bleed- not yet been published. Recently, based on a ing. If necessary, they may be removed by morphological study of 13 patients, Zaballos et ­surgery (larger lesions), cryotherapy (10-s al. have evaluated the dermoscopic findings of freeze–thaw cycle with a 1-mm margin), elec- pyogenic granuloma. The most frequently ob- trosurgery or laser (potassium titanyl phosphate served features were reddish homogeneous area vascular laser [6], flash-lamp-pumped pulsed- (92%), white collaratte (84%), “white rail” lines dye laser, or continuous-wave krypton laser [1]). that intersect the lesion (30%), and ulceration Laser-treated lesions undergo inflammation, (46%). It was concluded that the absence of spe- necrosis, and eventual healing by 4 weeks [1]. cific criteria for other skin tumors and a reddish Laser treatment is paralleled by psychological homogeneous area surrounded by a white col- benefit also [10]. larette were the most frequent dermoscopic pat- tern in pyogenic granuloma. The histopatho- logical counterparts were attributed to the V.5.3 Pyogenic Granuloma proliferating capillaries for reddish homoge- neous areas, to the hyperplastic epithelium em- V.5.3.1 Definition bracing the lesion for “white collarette,” and to the fibrous septa surrounding the lobules for Pyogenic granuloma (lobular capillary heman- “white rail” lines [35]. A preliminary study on gioma, granuloma telangiectaticum, granuloma dermoscopic findings of pyogenic granuloma of pregnancy) is a shiny red, often friable, and was also carried out in our dermoscopy unit. In bleeding nodular lesion that develops rapidly, a period of 3 months, 11 histopathologically often following trauma, on the skin and mucosa confirmed cases of pyogenic granuloma were of children, young adults and pregnant women. included. The most commonly occurring fea- tures were reddish and whitish homogeneous area (82%), white collaratte (55%), “white fence,” V.5.3.2 Clinical Features the rods intersecting the lesion (82%), and ul- ceration (55%). It was concluded that the most Pyogenic granuloma arises as solitary, soft, frequent dermoscopic pattern in pyogenic gran- bright-red papule evolving rapidly in a few uloma was reddish and whitish homogeneous weeks and forming a darker, slightly peduncu- area with white fence (82%) and the other two lated nodule, measuring up to 2–3 cm, with a findings occurred in more than half of the pa- frequently eroded and crusted surface which tients (Fig. V.5.2b). Considering these two stud- may bleed very easily (Fig. V.5.2a) [25]. It is ies, it can be concluded that dermoscopy is a fa- common in one specific clinical setting, the gin- cilitative method in the diagnosis of pyogenic giva in pregnancy [8]. The areas subject to trau- granuloma. ma, the hands (especially the fingers), forearms, 306 F. Özdemir Fig. V.5.2. a Pyogenic granuloma, clinical view. A soft, dark-red nodule 8×10 mm in diameter with a shiny, partly eroded surface is shown. b Pyogenic granuloma, dermoscopy view (inset shows lower magnification). A reddish and whitish homogeneous area with a partial white collaratte (white arrow) and rods intersecting the lesion, namely, “white fence” (black arrows) and some ulceration at the periphery are shown V.5.3.4 Relevant Clinical Differential V.5.3.5 Histopathology Diagnosis The microscopic diagnosis is usually straightfor- Pyogenic granuloma includes malignant skin ward. Pyogenic granuloma is simply composed tumors, namely, hypo-apigmented melanoma, of aggregates of angiomatous lobules. These lob- basal cell carcinoma and squamous cell car­ ular aggregates of proliferating capillaries are cinoma, Kaposi’s sarcoma, glomus tumor, and within a fibromyxoid or collagenous stroma benign lesions such as multifocal infantile which is infiltrated by inflammatory cells. As the hemangiomas, cherry hemangioma, bacillary lesion grows old, the capillary lumens become angiomatosis, angiolymphoid hyperplasia with more dilated and evident. When the surface is eosinophilia, or milker’s nodule. The most im- ulcerated, the stroma becomes markedly infil- V.5 portant one, melanoma, cannot be excluded trated by neutrophils. In these lesions fibrin, with confidence without a biopsy.
Recommended publications
  • Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
    16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma .
    [Show full text]
  • The Health-Related Quality of Life of Sarcoma Patients and Survivors In
    Cancers 2020, 12 S1 of S7 Supplementary Materials The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of A Nationwide Observational Study (PROSa) Martin Eichler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Jens Jakob, Susanne Singer, Robert Grützmann, Stephen Fung, Eva Wardelmann, Karin Arndt, Vitali Heidt, Christine Hofbauer, Marius Fried, Verena I. Gaidzik, Karl Verpoort, Marit Ahrens, Jürgen Weitz, Klaus-Dieter Schaser, Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler and the PROSa study group Includes Entities We included sarcomas according to the following WHO classification. - Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 p. (World Health Organization classification of tumours). - Kurman RJ, International Agency for Research on Cancer, World Health Organization, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. 307 p. (World Health Organization classification of tumours). - Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106–19. - World Health Organization, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed.
    [Show full text]
  • Review Cutaneous Patterns Are Often the Only Clue to a a R T I C L E Complex Underlying Vascular Pathology
    pp11 - 46 ABstract Review Cutaneous patterns are often the only clue to a A R T I C L E complex underlying vascular pathology. Reticulate pattern is probably one of the most important DERMATOLOGICAL dermatological signs of venous or arterial pathology involving the cutaneous microvasculature and its MANIFESTATIONS OF VENOUS presence may be the only sign of an important underlying pathology. Vascular malformations such DISEASE. PART II: Reticulate as cutis marmorata congenita telangiectasia, benign forms of livedo reticularis, and sinister conditions eruptions such as Sneddon’s syndrome can all present with a reticulate eruption. The literature dealing with this KUROSH PARSI MBBS, MSc (Med), FACP, FACD subject is confusing and full of inaccuracies. Terms Departments of Dermatology, St. Vincent’s Hospital & such as livedo reticularis, livedo racemosa, cutis Sydney Children’s Hospital, Sydney, Australia marmorata and retiform purpura have all been used to describe the same or entirely different conditions. To our knowledge, there are no published systematic reviews of reticulate eruptions in the medical Introduction literature. he reticulate pattern is probably one of the most This article is the second in a series of papers important dermatological signs that signifies the describing the dermatological manifestations of involvement of the underlying vascular networks venous disease. Given the wide scope of phlebology T and its overlap with many other specialties, this review and the cutaneous vasculature. It is seen in benign forms was divided into multiple instalments. We dedicated of livedo reticularis and in more sinister conditions such this instalment to demystifying the reticulate as Sneddon’s syndrome. There is considerable confusion pattern.
    [Show full text]
  • Kaposiform Hemangioendothelioma with Kasabach-Merritt Syndrome Mistaken for Child Abuse in a Newborn
    Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome Mistaken for Child Abuse in a Newborn Amanda A. Cyrulnik, MD; Manju C. Dawkins, MD; Gert J. Smalberger, MD; Scott Young, MD; Ranon E. Mann, MD; Mark I. Jacobson, MD; Adam J. Friedman, MD Practice Points Vascular tumors in dermatology may mimic child abuse. Even when all signs favor abuse, a nonresolving lesion should alarm clinicians to consider an alter- nate diagnosis. Kasabach-Merritt syndrome is a serious and potentially life-threatening condition that requires prompt evaluation. Kaposiform hemangioendotheliomaCUTIS is a rare vas- elevated D-dimer levels, confirming a diagnosis of cular neoplasm of childhood that may have an Kasabach-Merritt syndrome (KMS). alarming and potentially misleading clinical pre- Cutis. 2014;93:E17-E20. sentation. Awareness of this entity is important to provide appropriate and immediate medical care. Case Report We report the case of a 24-day-old female new- A 24-day-old female newborn presented to a hospi- born who presented with a large bruiselike lesion tal with a large bruiselike lesion on the left leg. A on theDo left leg. A diagnosis ofNot cellulitis suspected diagnosis Copy of cellulitis suspected to be secondary to to be secondary to child abuse was made and the child abuse was made and the patient subsequently patient subsequently was placed in foster care; was placed in foster care; however, the lesion did not however, the lesion did not resolve after treatment resolve after treatment and relocation. At 69 days of and relocation. On reevaluation at our institution, age, the patient was readmitted, now to our hospi- physical examination revealed a round, 34-cm, tal, after the lesion persisted and had progressively violaceous, indurated, fixed, nonblanching, non- expanded.
    [Show full text]
  • Glomus Tumor in the Floor of the Mouth: a Case Report and Review of the Literature Haixiao Zou1,2, Li Song1, Mengqi Jia2,3, Li Wang4 and Yanfang Sun2,3*
    Zou et al. World Journal of Surgical Oncology (2018) 16:201 https://doi.org/10.1186/s12957-018-1503-6 CASEREPORT Open Access Glomus tumor in the floor of the mouth: a case report and review of the literature Haixiao Zou1,2, Li Song1, Mengqi Jia2,3, Li Wang4 and Yanfang Sun2,3* Abstract Background: Glomus tumors are rare benign neoplasms that usually occur in the upper and lower extremities. Oral cavity involvement is exceptionally rare, with only a few cases reported to date. Case presentation: A 24-year-old woman with complaints of swelling in the left floor of her mouth for 6 months was referred to our institution. Her swallowing function was slightly affected; however, she did not have pain or tongue paralysis. Enhanced computed tomography revealed a 2.8 × 1.8 × 2.1 cm-sized well-defined, solid, heterogeneous nodule above the mylohyoid muscle. The mandible appeared to be uninvolved. The patient underwent surgery via an intraoral approach; histopathological examination revealed a glomus tumor. The patient has had no evidence of recurrence over 4 years of follow-up. Conclusions: Glomus tumors should be considered when patients present with painless nodules in the floor of the mouth. Keywords: Glomus tumor, Floor of mouth, Oral surgery Background Case presentation Theglomusbodyisaspecialarteriovenousanasto- A 24-year-old woman with a 6-month history of swelling mosisandfunctionsinthermalregulation.Glomustu- in the left floor of her mouth was referred to our institu- mors are rare, benign, mesenchymal tumors that tion. Although she experienced slight difficulty in swal- originate from modified smooth muscle cells of the lowing, she did not experience pain or tongue paralysis.
    [Show full text]
  • Cutaneous Manifestations of Newborns in Omdurman Maternity Hospital
    ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ Cutaneous Manifestations of Newborns in Omdurman Maternity Hospital A thesis submitted in the partial fulfillment of the degree of clinical MD in pediatrics and child health University of Khartoum By DR. AMNA ABDEL KHALIG MOHAMED ATTAR MBBS University of Khartoum Supervisor PROF. SALAH AHMED IBRAHIM MD, FRCP, FRCPCH Department of Pediatrics and Child Health University of Khartoum University of Khartoum The Graduate College Medical and Health Studies Board 2008 Dedication I dedicate my study to the Department of Pediatrics University of Khartoum hoping to be a true addition to neonatal care practice in Sudan. i Acknowledgment I would like to express my gratitude to my supervisor Prof. Salah Ahmed Ibrahim, Professor of Peadiatric and Child Health, who encouraged me throughout the study and provided me with advice and support. I am also grateful to Dr. Osman Suleiman Al-Khalifa, the Dermatologist for his support at the start of the study. Special thanks to the staff at Omdurman Maternity Hospital for their support. I am also grateful to all mothers and newborns without their participation and cooperation this study could not be possible. Love and appreciation to my family for their support, drive and kindness. ii Table of contents Dedication i Acknowledgement ii Table of contents iii English Abstract vii Arabic abstract ix List of abbreviations xi List of tables xiii List of figures xiv Chapter One: Introduction & Literature Review 1.1 The skin of NB 1 1.2 Traumatic lesions 5 1.3 Desquamation 8 1.4 Lanugo hair 9 1.5
    [Show full text]
  • Eyelid Conjunctival Tumors
    EYELID &CONJUNCTIVAL TUMORS PHOTOGRAPHIC ATLAS Dr. Olivier Galatoire Dr. Christine Levy-Gabriel Dr. Mathieu Zmuda EYELID & CONJUNCTIVAL TUMORS 4 EYELID & CONJUNCTIVAL TUMORS Dear readers, All rights of translation, adaptation, or reproduction by any means are reserved in all countries. The reproduction or representation, in whole or in part and by any means, of any of the pages published in the present book without the prior written consent of the publisher, is prohibited and illegal and would constitute an infringement. Only reproductions strictly reserved for the private use of the copier and not intended for collective use, and short analyses and quotations justified by the illustrative or scientific nature of the work in which they are incorporated, are authorized (Law of March 11, 1957 art. 40 and 41 and Criminal Code art. 425). EYELID & CONJUNCTIVAL TUMORS EYELID & CONJUNCTIVAL TUMORS 5 6 EYELID & CONJUNCTIVAL TUMORS Foreword Dr. Serge Morax I am honored to introduce this Photographic Atlas of palpebral and conjunctival tumors,which is the culmination of the close collaboration between Drs. Olivier Galatoire and Mathieu Zmuda of the A. de Rothschild Ophthalmological Foundation and Dr. Christine Levy-Gabriel of the Curie Institute. The subject is now of unquestionable importance and evidently of great interest to Ophthalmologists, whether they are orbital- palpebral specialists or not. Indeed, errors or delays in the diagnosis of tumor pathologies are relatively common and the consequences can be serious in the case of malignant tumors, especially carcinomas. Swift diagnosis and anatomopathological confirmation will lead to a treatment, discussed in multidisciplinary team meetings, ranging from surgery to radiotherapy.
    [Show full text]
  • Benign Hemangiomas
    TUMORS OF BLOOD VESSELS CHARLES F. GESCHICKTER, M.D. (From tke Surgical Palkological Laboratory, Department of Surgery, Johns Hopkins Hospital and University) AND LOUISA E. KEASBEY, M.D. (Lancaster Gcaeral Hospital, Lancuster, Pennsylvania) Tumors of the blood vessels are perhaps as common as any form of neoplasm occurring in the human body. The greatest number of these lesions are benign angiomas of the body surfaces, small elevated red areas which remain without symptoms throughout life and are not subjected to treatment. Larger tumors of this type which undergb active growth after birth or which are situated about the face or oral cavity, where they constitute cosmetic defects, are more often the object of surgical removal. The majority of the vascular tumors clinically or pathologically studied fall into this latter group. Benign angiomas of similar pathologic nature occur in all of the internal viscera but are most common in the liver, where they are disclosed usually at autopsy. Angiomas of the bone, muscle, and the central nervous system are of less common occurrence, but, because of the symptoms produced, a higher percentage are available for study. Malignant lesions of the blood vessels are far more rare than was formerly supposed. An occasional angioma may metastasize following trauma or after repeated recurrences, but less than 1per cent of benign angiomas subjected to treatment fall into this group. I Primarily ma- lignant tumors of the vascular system-angiosarcomas-are equally rare. The pathological criteria for these growths have never been ade- quately established, and there is no general agreement as to this par- ticular form of tumor.
    [Show full text]
  • Reconstructive
    RECONSTRUCTIVE Differential Diagnosis of Lower Extremity Enlargement in Pediatric Patients Referred with a Diagnosis of Lymphedema Carolyn C. Schook, B.A. Background: There are many causes for a large lower limb in the pediatric age John B. Mulliken, M.D. group. These children are often mislabeled as having lymphedema, and incor- Steven J. Fishman, M.D. rect diagnosis can lead to improper treatment. The purpose of this study was to Ahmad I. Alomari, M.D. determine the differential diagnosis in pediatric patients referred for lower Frederick D. Grant, M.D. extremity “lymphedema” and to clarify management. Arin K. Greene, M.D., Methods: The authors’ Vascular Anomalies Center database was reviewed be- M.M.Sc. tween 1999 and 2010 for patients referred with a diagnosis of lymphedema of Boston, Mass. the lower extremity. Records were studied to determine the correct cause for the enlarged extremity. Alternative diagnoses, sex, age of onset, and imaging studies were also analyzed. Results: A referral diagnosis of lower extremity lymphedema was given to 170 children; however, the condition was confirmed in only 72.9 percent of patients. Forty-six children (27.1 percent) had another disorder: microcystic/macrocystic lymphatic malformation (19.6 percent), noneponymous combined vascular malformation (13.0 percent), capillary malformation (10.9 percent), Klippel- Trenaunay syndrome (10.9 percent), hemihypertrophy (8.7 percent), posttrau- matic swelling (8.7 percent), Parkes Weber syndrome (6.5 percent), lipedema (6.5 percent), venous malformation (4.3 percent), rheumatologic disorder (4.3 percent), infantile hemangioma (2.2 percent), kaposiform hemangioendothe- lioma (2.2 percent), or lipofibromatosis (2.2 percent).
    [Show full text]
  • 8.5 X12.5 Doublelines.P65
    Cambridge University Press 978-0-521-87409-0 - Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions Edited by Markku Miettinen Index More information Index abdominal ependymoma, 744 mucinous cystadenocarcinoma, 631 adult fibrosarcoma (AF), 364–365, 1026 abdominal extrauterine smooth muscle ovarian adenocarcinoma, 72, 79 adult granulosa cell tumor, 523–524 tumors, 79 pancreatic adenocarcinoma, 846 clinical features, 523 abdominal inflammatory myofibroblastic pulmonary adenocarcinoma, 51 genetics, 524 tumors, 297–298 renal adenocarcinoma, 67 pathology, 523–524 abdominal leiomyoma, 467, 477 serous cystadenocarcinoma, 631 adult rhabdomyoma, 548–549 abdominal leiomyosarcoma. See urinary bladder/urogenital tract clinical features, 548 gastrointestinal stromal tumor adenocarcinoma, 72, 401 differential diagnosis, 549 (GIST) uterine adenocarcinomas, 72 genetics, 549 abdominal perivascular epithelioid cell tumors adenofibroma, 523 pathology, 548–549 (PEComas), 542 adenoid cystic carcinoma, 1035 aggressive angiomyxoma (AAM), 514–518 abdominal wall desmoids, 244 adenomatoid tumor, 811–813 clinical features, 514–516 acquired elastotic hemangioma, 598 adenomatous polyposis coli (APC) gene, 143 differential diagnosis, 518 acquired tufted angioma, 590 adenosarcoma (mullerian¨ adenosarcoma), 523 genetics, 518 acral arteriovenous tumor, 583 adipocytic lesions (cytology), 1017–1022 pathology, 516 acral myxoinflammatory fibroblastic sarcoma atypical lipomatous tumor/well- aggressive digital papillary adenocarcinoma, (AMIFS), 365–370, 1026 differentiated
    [Show full text]
  • Dermatopathology
    Dermatopathology Clay Cockerell • Martin C. Mihm Jr. • Brian J. Hall Cary Chisholm • Chad Jessup • Margaret Merola With contributions from: Jerad M. Gardner • Talley Whang Dermatopathology Clinicopathological Correlations Clay Cockerell Cary Chisholm Department of Dermatology Department of Pathology and Dermatopathology University of Texas Southwestern Medical Center Central Texas Pathology Laboratory Dallas , TX Waco , TX USA USA Martin C. Mihm Jr. Chad Jessup Department of Dermatology Department of Dermatology Brigham and Women’s Hospital Tufts Medical Center Boston , MA Boston , MA USA USA Brian J. Hall Margaret Merola Department of Dermatology Department of Pathology University of Texas Southwestern Medical Center Brigham and Women’s Hospital Dallas , TX Boston , MA USA USA With contributions from: Jerad M. Gardner Talley Whang Department of Pathology and Dermatology Harvard Vanguard Medical Associates University of Arkansas for Medical Sciences Boston, MA Little Rock, AR USA USA ISBN 978-1-4471-5447-1 ISBN 978-1-4471-5448-8 (eBook) DOI 10.1007/978-1-4471-5448-8 Springer London Heidelberg New York Dordrecht Library of Congress Control Number: 2013956345 © Springer-Verlag London 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work.
    [Show full text]
  • Etiology and Clinical Outcome of Budd-Chiari Syndrome and Portal Vein Thrombosis
    Etiology and Clinical Outcome of Budd-Chiari Syndrome and Portal Vein Thrombosis Jildou Hoekstra ISBN: 978-90-8559-172-6 Financial support for printing of this thesis was kindly provided by the Department of Gastroenterology and Hepatology of the Erasmus University Medical Center, J.E. Jurriaanse Stichting and the Dutch Society of Hepatology (NVH). Printed by: Optima Grafische Communicatie, Rotterdam, the Netherlands Cover: photograph & design by Niels Agatz © 2010. Jildou Hoekstra, Rotterdam, the Netherlands. All rights reserved. No parts of this work may be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the author. Etiology and Clinical Outcome of Budd-Chiari Syndrome and Portal Vein Thrombosis Etiologie en klinisch beloop van Budd-Chiari syndroom en vena portae trombose Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de rector magnificus Prof.dr. H.G. Schmidt en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op vrijdag 17 december 2010 om 11:30 uur door Jildou Hoekstra geboren te Amstelveen PROMOTIECOMMISSIE Promotoren: Prof.dr. H.L.A. Janssen Prof.dr. F.W.G. Leebeek Overige leden: Prof.dr. H.J. Metselaar Prof.dr. P. Sonneveld Prof.dr. J.P.H. Drenth sin en wille kin folle tille CONTENTS Chapter 1 Introduction 9 Chapter 2 Etiologic factors underlying Budd-Chiari syndrome and portal vein 35 thrombosis: clues for site-specific thrombosis
    [Show full text]